Overview
- 8 FDA inspections are on record.
- 7 inspections produced a Form 483.
- The most recent recorded inspection date is 2026-05-19.
At a glance
Inspections
8
Form 483s
7
EIRs
0
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 12 May 2026 – 19 May 2026 | Human Drugs | 483 | View 483 → |
| 17 May 2023 – 24 May 2023 | Human Drugs | 483 | View 483 → |
| 25 Jul 2022 – 5 Aug 2022 | Human Drugs | 483 | View 483 → |
| 13 Jan 2020 – 17 Jan 2020 | Human Drugs | Clean | |
| 23 Jul 2018 – 27 Jul 2018 | Human Drugs | 483 | On file |
| 10 Jul 2017 – 21 Jul 2017 | Human Drugs | 483 | On file |
| 16 May 2016 – 3 Jun 2016 | Human Drugs | 483 | View 483 → |
| 9 Sep 2015 – 17 Sep 2015 | Human Drugs | 483 | View 483 → |
Observations on record
Form 483 observations cited at this site, most recent first.
19 May 2026
21 CFR 211.192
Investigations of discrepancies, failures
Cited by Roger F Zabinski, Eric Zhu, Conor J Mccarron, Ana-Maria A Plapcianu
5 Aug 2022
21 CFR 211.192
Extent of discrepancy, failure investigations
Cited by Nathaniel B Phillips Sylvain, Crystal Monroy
Investigators
FDA investigators tied to this site in the record.
Christopher R Czajka2 insp.
Robert D Tollefsen2 insp.
Anita Narula2 insp.
Roger F Zabinski1 insp.
Eric Zhu1 insp.
Conor J Mccarron1 insp.
Ana-Maria A Plapcianu1 insp.
Huiquan Wu1 insp.
Hung H Do1 insp.
Nathaniel B Phillips Sylvain1 insp.
Crystal Monroy1 insp.
Nicholas L Hunt1 insp.
Sridhar Thumma1 insp.
Zachary A Bogorad1 insp.
Chiaochun J Wang1 insp.
Gloria J Baca1 insp.
Ko U Min1 insp.
Tracy K Li1 insp.
Marijo B Kambere1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 5x |
| 21 CFR 211.68(b) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.100(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.103 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.160(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.166(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.188 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.188(b)(8) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.194(a)(4) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.194(a)(8) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.194(c) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.198(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.25(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.63 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.67(b)(3) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.84(d)(1) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.84(d)(2) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.94(b) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Lonza Bend Inc.'s 7 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat